Skip to main content
Caplight Logo









Marsi Bionics

Marsi Bionics

Private
MadridHealthcare & Life Scienceshttps://marsibionics.com/

Last Round

VC Round

Jun 27, 2023

Total Funding Raised

$4.14M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Marsi Bionics is a medical robotics company that develops and produces pediatric wearable exoskeletons designed for gait therapy and mobility in children with neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

robotic exoskeletonwearable exoskeletongait rehabilitationexosuitbionic suitpediatric exoskeletonrehab techmedical devicesassistive technologymedical AIrobotic knee bracecerebral palsy treatmentstroke rehabilitationvariable stiffness joints

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Marsi Bionics Comparables

Compare Marsi Bionics with similar companies based on industry and business-model similarity.

Marsi Bionics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wandercraft
85%
GOGOA Mobility Robots
84%
ABLE Human Motion
84%

Marsi Bionics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 27, 2023
GrantSep 16, 2022
CrowdfundingJun 1, 2021
GrantMar 1, 2018

Key People

Founding team and executive leadership

Alberto Plaza Flores

Director técnico (CTO)

Executive Team

Marsi Bionics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors grew 68% MoM, reaching 6.2K.

  • Jul 29, 2026

    Monthly visitors grew 158% MoM, reaching 5.6K.

Marsi Bionics Filings

Explore SEC and related filing metadata, where available.

Marsi Bionics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Marsi Bionics's valuation, stock price, and market status.

Is Marsi Bionics a public or private company?

Marsi Bionics is a private company.

What is the current stock price of Marsi Bionics?

Marsi Bionics is a private company, so its shares have no public market price. Caplight tracks Marsi Bionics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Marsi Bionics worth (valuation)?

Valuation information for Marsi Bionics is not publicly available.

Can I buy Marsi Bionics stock?

Marsi Bionics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Marsi Bionics's last funding round?

Marsi Bionics's most recent funding round was VC Round on June 27, 2023.

Who are the main investors in Marsi Bionics?

Key investors in Marsi Bionics include ION ION, European Innovation Council Fund, Orilla Asset Management, Center for Technological Development and Innovation, Fellow Funders.

Will Marsi Bionics IPO soon?

No public IPO plans have been announced for Marsi Bionics.

How can I track Marsi Bionics secondary market activity?

Caplight tracks bids, offers, and trades in Marsi Bionics's shares on secondary markets.

Firmographic Details

HeadquartersMadrid
Employee Range55
Year Founded2013
Last FundingJun 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?